Archive for February, 2013

New Research Confirms Bonicel’s Multiple Anti-Aging Benefits

New science confirms Ganeden Biotech’s probiotic-derived ingredient improves skin moisturization and elasticity while reducing fine lines and wrinkles.

(PRWeb February 05, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10397662.htm


Probiotic Action Comments on Acne Statistics by WebMD

A recent article by WebMD discussed the alarming statistics of how many suffer from Acne, Probiotic Acne responds with advice on treatment options.(PRWeb February 05, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10365660.htm


Unusual Method on How to Get Rid of Bed Bugs Without Pesticides Has…

My Cleaning Products posted a guide on how to get rid of bed bugs effectively and safely without spending thousands in bed bug treatment. The website published the guideline in response to the release…(PRWeb February 05, 2013)Read the full story a…


Deborah Morosini, MD Pathologist and Patient Advocate Signs on as…

Deborah Morosini, MD, philanthropist and the sister of the late Dana Reeve, signs on as medical director and advisory board member of Store-A-Tooth dental stem cell banking. She will review the…(PRWeb February 05, 2013)Read the full story at http…


NDIS Approval of the Promega PowerPlex(R) Y23 System Enables More…

The Promega PowerPlex(R) Y23 System is now approved for use in laboratories that generate DNA records for the National DNA Index System (NDIS).(PRWeb February 05, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10394137.htm


Cutting the Cost of Clinical Research: The Solution Comes from Russia,…

Xtalks presents an exciting live webinar on Monday, February 25, 2013 at 11:00am EST on developing potency assays for validation. Join experts from Synergy Research – Dr. Sergei Varshavsky and Mr….

(PRWeb February 05, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10385980.htm


Drug Patent Expirations for Jan 13 2013

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations

Journal of Commercial Biotechnology

Advertise
here

This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents





Drug Patent Expirations for January 13 2013

Tradename Applicant Generic Name Patent
Expiration
LOTRONEX Prometheus Labs alosetron hydrochloride Jan 13, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.



DrugPatentWatch
Infographics

Future drug patent expirations by month

Patent Expirations by
Month

More
infographics &raquo





DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.


OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)

Visit booth #39 to see how OpenClinica enhances clinical trial productivity while enabling greater freedom and control over your technology.(PRWeb February 05, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10395331.htm